Zdrowie i gospodarka · 07/09/2000
FDA Requests Public Comment on Proposed Changes to Approved NDAs or ANDAs
The Food and Drug Administration (FDA) is seeking public input on proposed changes to its guidance for industry regarding approved New Drug Applications (NDAs) or Abbreviated New Drug Applications (ANDAs), as required by the Paperwork Reduction Act of 1995.
Source: Federal Register — Food and Drug AdministrationOpen original release →